American Academy of Ophthalmology (AAO) 2024
Pegcetacoplan for GA: Update on Clinical Studies and Real-World Experience
Efficacy and Safety of Continuous Pegcetacoplan Treatment for Subfoveal GA in AMD: 36-Month Results from OAKS, DERBY, and GALE Open-Label Extension
The following information is available for educational purposes only. The information is not to be re-purposed or re-used in its current form or presentation for any personal or professional use. Apellis reserves the right to withdraw, modify or change the information that is available on this website at any time.